Tools hub
Financial Calculators
Private, in-browser — no account required.
Recent
quick returnPopular searches
live pathsNASDAQ · HEALTHCARE
$406.78
▲ +$4.60(+1.14%)4:00 PM ET - vs previous closeiQuote as of Jun 18, 2026, 4:00 PM EDT
After-hours NASDAQ quote as of Jun 18, 2026, 4:00 PM EDT. Extended-hours prices can sit outside the regular-session range.
Market data source
Chart
Latest 1D session
1Y · weekly bars · USD · Live $406.78 · 253 pts
Live checkTrade access
Affiliate disclosure: TECHi may earn a commission on links to broker partners. Read more.
Data freshness status
Price, fundamentals, analyst context, and news refresh through the unified quote cache.
Prices update fastest. Fundamentals, analyst data, and news update on their own schedules, so check these timestamps before comparing signals.
Price time means the latest available trade or regular-market close. Other times show when that section was checked or published.
Investor playbook
The page is most useful as a monitor until one side gets cleaner confirmation.
Use it for
Entry timing, risk check, and catalyst scan
What has to keep working for US investors to stay interested.
Cash yield
0.6%$808.60M free-cash-flow base.
Multiple compressing
-22.5%Forward P/E sits below trailing — estimates imply earnings growing into the multiple.
Where the dashboard says the thesis can break or get crowded.
Growth priced in
2.11PEG above 2 can leave less room for execution misses.
Trend pressure
-17.3%Price is materially below the 200-day average.
Catalysts and positioning checks that are not duplicate live-pulse metrics.
Latest catalyst
Yahoo1 Unstoppable Medical Juggernaut to Buy Hand Over Fist and Hold for the Next 50 Years
The playbook is derived from quote, analyst, financial, news, and trend snapshots. It is a research workflow aid, not a buy or sell recommendation.
Evidence quality
Core quote, source, and timing signals are available for this snapshot.
86
Strong evidence
Price
Latest quote, session range, volume, and price timing.
Fundamentals
Size, valuation, profitability, yield, and balance-sheet context.
Analyst
Street target, rating mix, revisions, and event setup.
News
Current catalyst headlines, sentiment, and source recency.
Provider state
28 live / 21 fallback
7 unavailable inputs: Fundamentals Debt To Equity, Analyst Next Earnings Date, Strategic Roadmap. Provider fallback state is shown above when a live lane fails.
Score is derived from source attribution, provider state, timing, and field coverage. It explains confidence in the dashboard evidence, not investment merit.
Buy analyst tone. Latest catalyst: 1 Unstoppable Medical Juggernaut to Buy Hand Over Fist and Hold for the Next 50 Years (Yahoo). Premium valuation — growth priced in.
Balanced watch. Future value (74/100) is the strongest signal; momentum setup (40/100) is the main constraint. Model confidence is 45/100 from 68 of 76 available inputs and a 78% freshness factor; 8 inputs are missing, so treat this as a directional research screen rather than a forecast. Analyst disagreement penalty is applied through the confidence model; the Analyst View card owns the published spread. Long-term secular context is tracked separately: 20 Years +3526.9% total (97/100 progress score); yesterday -3.6%. Rolling price-history validation is 14% across 1066 matured horizon scores; full field-by-field accuracy still needs stored daily snapshots.
Expected-return math is scaled by beta and realized volatility before confidence is applied.
Short-horizon expected moves are volume-weighted so thin moves get less credit than confirmed tape.
VIX and sector ETF momentum are companion covariables; when source data lacks them, TECHi labels the gap instead of fabricating precision.
Roadmap, leadership, human-impact, and social/developer traction proxy durable moat until issuer-level software recurring revenue is available.
| Enterprise value | $137.88B |
| Price / sales | 13.46 |
| Price / book | 8.15 |
| Operating margin | 30.90% |
| Return on assets | 10.20% |
| EPS (TTM) | $8.22 |
| Beta (5Y) | 1.45 |
Benchmark context
Compare against its sector ETF and the broad market.
Help · FAQ
4 answers covering the latest ISRG price, analyst view, leadership, and sector context.
Prices, ratios, and TECHi research signals can be live, delayed, cached, unavailable, or revised by providers.
TECHi.com